Neopharm Group

Company Overview

Snapshot

Founded in January 1941 by David Fuhrer, Neopharm Group operates with 51–200 employees. In November 2025, the company expanded its Israeli distribution capabilities through its subsidiary Eldan, partnering with FIZE Medical.

Business overview

Neopharm Group is a family of companies engaged in the research, development, manufacturing, marketing, sales, and distribution of a wide array of products within the healthcare market, reaching over 60 countries. The company focuses on three primary segments: pharmaceutical, consumer healthcare, and medical devices, operating within the Health Tech & Life Sciences sector.

Strategic signal

In November 2025, Neopharm Group's subsidiary, Eldan, secured an investment and distribution agreement with FIZE Medical, a leader in smart fluid management solutions. This partnership signals Neopharm's strategic expansion in the medical devices segment and its commitment to integrating innovative healthcare technologies into its distribution network, enhancing its market position in Israel.

Company Intelligence Q&A

What is Neopharm Group's primary focus?

Neopharm Group focuses on the research, development, manufacturing, marketing, sales, and distribution of products across pharmaceutical, consumer healthcare, and medical device segments.

When was Neopharm Group founded?

Neopharm Group was founded in January 1941.

Who founded Neopharm Group?

Neopharm Group was founded by David Fuhrer, who also serves as its Owner, Chairman, and CEO.

What was a recent strategic partnership for Neopharm Group?

In November 2025, Neopharm Group's subsidiary Eldan partnered with FIZE Medical to secure an investment and expand Israeli distribution for FIZE Medical's smart fluid management solutions.

Did Neopharm Group enter into any licensing agreements recently?

In March 2023, Neopharm Group signed a license agreement with Amylyx for an ALS therapy.